In this study, we repurposed and characterized a dual-function, inducible RIPK3-driven necroptotic suicide system that functions as a safety switch and can synergistically boost the efficiency of cancer cell–based immunotherapy, which in turn induces long-term immunity that prevents recurrence. Here, RIPK3 is linked to cancer.